Christopher Gibson is Chief Executive Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 736,633 shares of RXRX, which is worth approximately $4.2 Million. The most recent transaction as insider was on Nov 15, 2024, when has been sold 26,023 shares (Class A Common Stock) at a price of $6.17 per share, resulting in proceeds of $160,561. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 737K
0.14% 3M change
10.16% 12M change
Total Value Held $4.2 Million

Christopher Gibson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 15 2024
SELL
Payment of exercise price or tax liability
$160,561 $6.17 p/Share
26,023 Reduced 3.41%
736,633 Class A Common Stock
Nov 14 2024
SELL
Open market or private sale
$147,000 $7.35 p/Share
20,000 Reduced 2.56%
762,656 Class A Common Stock
Nov 14 2024
BUY
Conversion of derivative security
-
20,000 Added 2.49%
782,656 Class A Common Stock
Nov 13 2024
SELL
Open market or private sale
$154,800 $7.74 p/Share
20,000 Reduced 2.56%
762,656 Class A Common Stock
Nov 13 2024
BUY
Conversion of derivative security
-
20,000 Added 2.49%
782,656 Class A Common Stock
Oct 03 2024
SELL
Open market or private sale
$121,600 $6.08 p/Share
20,000 Reduced 2.56%
762,656 Class A Common Stock
Oct 03 2024
BUY
Conversion of derivative security
-
20,000 Added 2.49%
782,656 Class A Common Stock
Oct 02 2024
SELL
Open market or private sale
$123,200 $6.16 p/Share
20,000 Reduced 2.56%
762,656 Class A Common Stock
Oct 02 2024
BUY
Conversion of derivative security
-
20,000 Added 2.49%
782,656 Class A Common Stock
Sep 05 2024
SELL
Open market or private sale
$122,800 $6.14 p/Share
20,000 Reduced 2.56%
762,656 Class A Common Stock
Sep 05 2024
BUY
Conversion of derivative security
-
20,000 Added 2.49%
782,656 Class A Common Stock
Sep 04 2024
SELL
Open market or private sale
$120,800 $6.04 p/Share
20,000 Reduced 2.56%
762,656 Class A Common Stock
Sep 04 2024
BUY
Conversion of derivative security
-
20,000 Added 2.49%
782,656 Class A Common Stock
Aug 30 2024
BUY
Exercise of conversion of derivative security
$12,400 $2.48 p/Share
5,000 Added 0.65%
762,656 Class A Common Stock
Aug 29 2024
BUY
Exercise of conversion of derivative security
$12,400 $2.48 p/Share
5,000 Added 0.66%
757,656 Class A Common Stock
Aug 28 2024
BUY
Exercise of conversion of derivative security
$12,400 $2.48 p/Share
5,000 Added 0.66%
752,656 Class A Common Stock
Aug 27 2024
BUY
Exercise of conversion of derivative security
$12,400 $2.48 p/Share
5,000 Added 0.66%
747,656 Class A Common Stock
Aug 26 2024
BUY
Exercise of conversion of derivative security
$12,400 $2.48 p/Share
5,000 Added 0.67%
742,656 Class A Common Stock
Aug 23 2024
BUY
Exercise of conversion of derivative security
$12,400 $2.48 p/Share
5,000 Added 0.67%
737,656 Class A Common Stock
Aug 15 2024
SELL
Payment of exercise price or tax liability
$174,488 $6.69 p/Share
26,082 Reduced 3.44%
732,656 Class A Common Stock
Aug 08 2024
SELL
Open market or private sale
$130,000 $6.5 p/Share
20,000 Reduced 2.57%
758,738 Class A Common Stock
Aug 08 2024
BUY
Conversion of derivative security
-
20,000 Added 2.5%
778,738 Class A Common Stock
Aug 07 2024
SELL
Open market or private sale
$213,000 $7.1 p/Share
30,000 Reduced 3.8%
758,738 Class A Common Stock
Aug 07 2024
BUY
Conversion of derivative security
-
30,000 Added 3.66%
788,738 Class A Common Stock
Jul 11 2024
SELL
Open market or private sale
$373,500 $7.47 p/Share
50,000 Reduced 6.18%
758,738 Class A Common Stock
CG

Christopher Gibson

Chief Executive Officer
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX